A Study to Assess S-217622 in Participants With Renal Impairment and Healthy Participants
NCT05363215
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Impairment
Interventions
DRUG:
S-217622
Sponsor
Shionogi